BioAffinity Total Assets from 2010 to 2024

BIAFW Stock

USD 0.75 0.15 25.00%

BioAffinity Technologies Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 5 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

8.2 M

Current Value

5 M

Quarterly Volatility

3.5 M

Credit Downgrade

Yuan Drop

Covid

Check BioAffinity Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAffinity Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 262.1 K, Interest Expense of 35.3 K or Gross Profit of 831.2 K, as well as many indicators such as Price To Sales Ratio of 4.82, Dividend Yield of 0.0 or PTB Ratio of 2.78. BioAffinity financial statements analysis is a perfect complement when working with BioAffinity Technologies Valuation or Volatility modules.

Check out the analysis of BioAffinity Technologies Correlation against competitors.

Latest BioAffinity Technologies' Total Assets Growth Pattern

Below is the plot of the Total Assets of bioAffinity Technologies Warrant over the last few years. Total assets refers to the total amount of BioAffinity Technologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BioAffinity Technologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. BioAffinity Technologies' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioAffinity Technologies' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 8.22 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

BioAffinity Total Assets Regression Statistics

	Arithmetic Mean	2,238,413
	Geometric Mean	1,033,003
	Coefficient Of Variation	156.67
	Mean Deviation	2,489,859
	Median	658,810
	Standard Deviation	3,506,826
	Sample Variance	12.3T
	Range	12M
	R-Value	0.61
	Mean Square Error	8.2T
	R-Squared	0.38
	Significance	0.01
	Slope	481,851
	Total Sum of Squares	172.2T

BioAffinity Total Assets History

	2024	5 M
	2023	8.2 M
	2022	12.2 M
	2021	1.5 M
	2020	145.6 K

Other Fundumenentals of BioAffinity Technologies

Intangibles To Total Assets

BioAffinity Technologies Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Current Deferred Revenue	Intangible Assets
Total Assets		0.78	-0.85	-0.8	0.81	0.51	-0.33	0.95	-0.57	0.95	0.81	0.98	-0.91	0.95	0.98	-0.42	-0.42
Total Stockholder Equity	0.78		-0.96	-0.52	0.5	0.5	-0.8	0.74	-0.95	0.76	0.4	0.8	-0.82	0.77	0.82	-0.47	-0.47
Net Debt	-0.85	-0.96		0.49	-0.47	-0.33	0.73	-0.87	0.86	-0.76	-0.44	-0.85	0.79	-0.76	-0.87	0.31	0.31
Retained Earnings	-0.8	-0.52	0.49		-0.91	-0.84	-0.08	-0.67	0.32	-0.85	-0.87	-0.86	0.9	-0.88	-0.83	0.8	0.8
Accounts Payable	0.81	0.5	-0.47	-0.91		0.79	-0.02	0.62	-0.33	0.93	0.89	0.8	-0.85	0.93	0.78	-0.63	-0.63
Net Receivables	0.51	0.5	-0.33	-0.84	0.79		-0.1	0.29	-0.46	0.69	0.59	0.6	-0.79	0.73	0.58	-0.95	-0.95
Total Liab	-0.33	-0.8	0.73	-0.08	-0.02	-0.1		-0.32	0.91	-0.32	0.12	-0.3	0.33	-0.31	-0.34	0.04	0.04
Total Current Assets	0.95	0.74	-0.87	-0.67	0.62	0.29	-0.32		-0.52	0.82	0.7	0.94	-0.81	0.82	0.94	-0.27	-0.27
Short Term Debt	-0.57	-0.95	0.86	0.32	-0.33	-0.46	0.91	-0.52		-0.6	-0.16	-0.6	0.67	-0.61	-0.63	0.44	0.44
Common Stock	0.95	0.76	-0.76	-0.85	0.93	0.69	-0.32	0.82	-0.6		0.83	0.93	-0.94	1.0	0.93	-0.55	-0.55
Long Term Debt	0.81	0.4	-0.44	-0.87	0.89	0.59	0.12	0.7	-0.16	0.83		0.78	-0.74	0.82	0.75	-0.47	-0.47
Net Invested Capital	0.98	0.8	-0.85	-0.86	0.8	0.6	-0.3	0.94	-0.6	0.93	0.78		-0.96	0.94	1.0	-0.56	-0.56
Short Long Term Debt	-0.91	-0.82	0.79	0.9	-0.85	-0.79	0.33	-0.81	0.67	-0.94	-0.74	-0.96		-0.96	-0.96	0.74	0.74
Capital Stock	0.95	0.77	-0.76	-0.88	0.93	0.73	-0.31	0.82	-0.61	1.0	0.82	0.94	-0.96		0.94	-0.6	-0.6
Net Working Capital	0.98	0.82	-0.87	-0.83	0.78	0.58	-0.34	0.94	-0.63	0.93	0.75	1.0	-0.96	0.94		-0.54	-0.54
Current Deferred Revenue	-0.42	-0.47	0.31	0.8	-0.63	-0.95	0.04	-0.27	0.44	-0.55	-0.47	-0.56	0.74	-0.6	-0.54		1.0
Intangible Assets	-0.42	-0.47	0.31	0.8	-0.63	-0.95	0.04	-0.27	0.44	-0.55	-0.47	-0.56	0.74	-0.6	-0.54	1.0

Click cells to compare fundamentals

About BioAffinity Technologies Financial Statements

BioAffinity Technologies investors use historical fundamental indicators, such as BioAffinity Technologies' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioAffinity Technologies. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	8.2 M	5 M
Intangibles To Total Assets	0.24	0.22

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for BioAffinity Stock Analysis

When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC